Market Overview

From Biogen Call: Eloctate Could Be Facing Potential Approval Delay

Related BIIB
Morning Market Losers
Benzinga's Top #PreMarket Losers
Don't Panic Over Recent Tech Turmoil (Fox Business)

Posted-In: News FDA

 

Related Articles (BIIB)

Around the Web, We're Loving...

Get Benzinga's Newsletters